Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2008

01-03-2008 | Original Paper

Is Single-Cell Apoptosis Sufficient for the Diagnosis of Graft-Versus-Host Disease in the Colon?

Authors: Christopher V. Nguyen, David M. Kastenberg, Cuckoo Choudhary, Leo C. Katz, Anthony DiMarino, Juan P. Palazzo

Published in: Digestive Diseases and Sciences | Issue 3/2008

Login to get access

Abstract

Low-grade lesions of graft-versus-host disease (GVHD) in the colon are not uncommon. To determine if minimal diagnostic criteria can be established in such biopsies, we correlated histologic findings with clinical history and investigated the role of endoscopy and electron microscopy in establishing GVHD. About 85 colonic biopsies that were histologically consistent with GVHD from 47 bone-marrow transplant recipients were reviewed retrospectively. Of nine cases showing only a single apoptotic cell in the intestinal epithelium, only four lacked any confounding factors of GVHD. These cases, while too few to assess the utility of finding one apoptotic cell with statistical significance, appear to support the idea that in the appropriate clinical setting, a single apoptotic cell could be reported as possibly representing early GVHD. Endoscopic findings did not reliably correlate with histology. Although electron microscopy can be a useful adjunct, it does not contribute to the diagnosis of GVHD.
Literature
1.
go back to reference Wagner JE Jr, Vogelsang GB, Beschorner WE (1989) Pathogenesis and pathology of graft-vs.-host disease. J Pediatr Hematol Oncol 11:196–212 Wagner JE Jr, Vogelsang GB, Beschorner WE (1989) Pathogenesis and pathology of graft-vs.-host disease. J Pediatr Hematol Oncol 11:196–212
2.
go back to reference Terdiman JP, Linker CA, Ries CA, Damon LE, Rugo HS, Ostroff JW (1996) The role of endoscopic evaluation in patients with suspected intestinal graft-versus-host disease after allogenic bone-marrow transplantation. Endoscopy 28:680–685PubMedCrossRef Terdiman JP, Linker CA, Ries CA, Damon LE, Rugo HS, Ostroff JW (1996) The role of endoscopic evaluation in patients with suspected intestinal graft-versus-host disease after allogenic bone-marrow transplantation. Endoscopy 28:680–685PubMedCrossRef
3.
go back to reference Spencer GD, Hackman RC, McDonald GB, Amos DE, Cunningham BA, Meyers JD, Thomas ED (1986) A prospective study of unexplained nausea and vomiting after marrow transplantation. Transplantation 42:602–607PubMedCrossRef Spencer GD, Hackman RC, McDonald GB, Amos DE, Cunningham BA, Meyers JD, Thomas ED (1986) A prospective study of unexplained nausea and vomiting after marrow transplantation. Transplantation 42:602–607PubMedCrossRef
4.
go back to reference Wu D, Hockenberry DM, Brentnall TA, Baehr PH, Ponec RJ, Kuver R, Tzung SP, Todaro JL, McDonald GB (1998) Persistent nausea and anorexia after marrow transplantation: a prospective study of 78 patients. Transplantation 66:1319–1324PubMedCrossRef Wu D, Hockenberry DM, Brentnall TA, Baehr PH, Ponec RJ, Kuver R, Tzung SP, Todaro JL, McDonald GB (1998) Persistent nausea and anorexia after marrow transplantation: a prospective study of 78 patients. Transplantation 66:1319–1324PubMedCrossRef
5.
go back to reference Iqbal N, Salzman D, Lazenby AJ, Wilcox CM (2000) Diagnosis of gastrointestinal graft-versus-host disease. Am J Gastroenterol 95:3034–3038PubMedCrossRef Iqbal N, Salzman D, Lazenby AJ, Wilcox CM (2000) Diagnosis of gastrointestinal graft-versus-host disease. Am J Gastroenterol 95:3034–3038PubMedCrossRef
6.
go back to reference Nash RA, Pepe MS, Storb R, Longton G, Pettinger M, Anasetti C, Appelbaum FR, Bowden RA, Deeg HJ, Doney K et al (1992) Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 80:1838–1845PubMed Nash RA, Pepe MS, Storb R, Longton G, Pettinger M, Anasetti C, Appelbaum FR, Bowden RA, Deeg HJ, Doney K et al (1992) Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 80:1838–1845PubMed
7.
8.
go back to reference Deeg HJ, Flowers ME, Leisenring W, Appelbaum FR, Martin PJ, Storb RF (2000) Cyclosporine (CSP) or CSP plus methylprednisolone for graft-versus-host disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial. Blood 96:1194–1195PubMed Deeg HJ, Flowers ME, Leisenring W, Appelbaum FR, Martin PJ, Storb RF (2000) Cyclosporine (CSP) or CSP plus methylprednisolone for graft-versus-host disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial. Blood 96:1194–1195PubMed
9.
go back to reference Peters C, Minkov M, Gadner H, Klingebiel T, Vossen J, Locatelli F, Cornish J, Ortega J, Bekasi A, Souillet G, Stary J, Niethammer D (2000) European group for blood and marrow transplantation (ebmt) working party paediatric diseases; international bfm study group—subcommittee bone marrow transplantation (IBFM-SG): statement of current majority practices of graft-versus-host disease prophylaxis and treatment in children. Bone Marrow Transplant 26:405–441PubMedCrossRef Peters C, Minkov M, Gadner H, Klingebiel T, Vossen J, Locatelli F, Cornish J, Ortega J, Bekasi A, Souillet G, Stary J, Niethammer D (2000) European group for blood and marrow transplantation (ebmt) working party paediatric diseases; international bfm study group—subcommittee bone marrow transplantation (IBFM-SG): statement of current majority practices of graft-versus-host disease prophylaxis and treatment in children. Bone Marrow Transplant 26:405–441PubMedCrossRef
10.
go back to reference Vermeer BJ, van der Spek-Keijser LM, Fibbe WE (1994) Skin biopsies in bone marrow transplantation. Lancet 344:75–76PubMedCrossRef Vermeer BJ, van der Spek-Keijser LM, Fibbe WE (1994) Skin biopsies in bone marrow transplantation. Lancet 344:75–76PubMedCrossRef
11.
go back to reference Wagner JL, Flowers ME, Longton G, Storb R, Schubert M, Sullivan KM (1998) The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation. Bone Marrow Transplant 22:139–146PubMedCrossRef Wagner JL, Flowers ME, Longton G, Storb R, Schubert M, Sullivan KM (1998) The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation. Bone Marrow Transplant 22:139–146PubMedCrossRef
12.
go back to reference Epstein RJ, McDonald GB, Sale GE, Shulman HM, Thomas ED (1980) The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients. Gastroenterology 78:764–771PubMed Epstein RJ, McDonald GB, Sale GE, Shulman HM, Thomas ED (1980) The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients. Gastroenterology 78:764–771PubMed
13.
go back to reference Sloane JP, Norton J (1993) The pathology of bone marrow transplantation. Histopathology 22:201–209PubMedCrossRef Sloane JP, Norton J (1993) The pathology of bone marrow transplantation. Histopathology 22:201–209PubMedCrossRef
14.
go back to reference Snover DC (1990) Graft-versus-host disease of the gastrointestinal tract. Am J Surg Pathol 14(Suppl):101–108PubMed Snover DC (1990) Graft-versus-host disease of the gastrointestinal tract. Am J Surg Pathol 14(Suppl):101–108PubMed
15.
go back to reference Snover DC (1985) Mucosal damage simulating acute graft-versus-host reaction in cytomegalovirus colitis. Transplantation 39:669–670PubMedCrossRef Snover DC (1985) Mucosal damage simulating acute graft-versus-host reaction in cytomegalovirus colitis. Transplantation 39:669–670PubMedCrossRef
16.
go back to reference Ponec RJ, Hackman RC, McDonald GB (1999) Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation. Gastrointest Endosc 49:612–621PubMedCrossRef Ponec RJ, Hackman RC, McDonald GB (1999) Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation. Gastrointest Endosc 49:612–621PubMedCrossRef
17.
go back to reference Lerner KG, Kao GF, Storb R, Buckner CD, Clift RA, Thomas ED (1974) Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc 6:367–371PubMed Lerner KG, Kao GF, Storb R, Buckner CD, Clift RA, Thomas ED (1974) Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc 6:367–371PubMed
18.
go back to reference Atkinson K (1999) Bone-marrow and blood stem-cell transplantation. In: Berry CL (ed) Transplantation pathology: a guide for practicing pathologists. Springer-Verlag Telos, New York Atkinson K (1999) Bone-marrow and blood stem-cell transplantation. In: Berry CL (ed) Transplantation pathology: a guide for practicing pathologists. Springer-Verlag Telos, New York
19.
go back to reference Brito GA, Fujji J, Carneiro-Filho BA, Lima AA, Obrig T, Guerrant RL (2002) Mechanism of Clostridium difficile toxin A-induced apoptosis in T84 cells. J Infect Dis 186:1438–1447PubMedCrossRef Brito GA, Fujji J, Carneiro-Filho BA, Lima AA, Obrig T, Guerrant RL (2002) Mechanism of Clostridium difficile toxin A-induced apoptosis in T84 cells. J Infect Dis 186:1438–1447PubMedCrossRef
20.
go back to reference McCole DF, Eckmann L, Laurent F, Kagnoff MF (2000) Intestinal epithelial cell apoptosis following Cryptosporidium parvum infection. Infect Immun 68:1710–1713PubMedCrossRef McCole DF, Eckmann L, Laurent F, Kagnoff MF (2000) Intestinal epithelial cell apoptosis following Cryptosporidium parvum infection. Infect Immun 68:1710–1713PubMedCrossRef
21.
go back to reference Driman DK, Preiksaitis HG (1998) Colorectal inflammation and increased cell proliferation associated with oral sodium phosphate bowel preparation solution. Hum Pathol 29:972–978PubMedCrossRef Driman DK, Preiksaitis HG (1998) Colorectal inflammation and increased cell proliferation associated with oral sodium phosphate bowel preparation solution. Hum Pathol 29:972–978PubMedCrossRef
22.
go back to reference Yeo M, Kim DK, Kim YB, Oh TY, Lee JE, Cho SW, Kim HC, Hahm KB (2004) Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells. Clin Cancer Res 10:8687–8696PubMedCrossRef Yeo M, Kim DK, Kim YB, Oh TY, Lee JE, Cho SW, Kim HC, Hahm KB (2004) Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells. Clin Cancer Res 10:8687–8696PubMedCrossRef
23.
go back to reference Izeradjene K, Revillard JP (2001) Apoptosis of superantigen-activated T cells induced by mycophenolate mofetil treatment. Transplantation 71:118–125PubMedCrossRef Izeradjene K, Revillard JP (2001) Apoptosis of superantigen-activated T cells induced by mycophenolate mofetil treatment. Transplantation 71:118–125PubMedCrossRef
Metadata
Title
Is Single-Cell Apoptosis Sufficient for the Diagnosis of Graft-Versus-Host Disease in the Colon?
Authors
Christopher V. Nguyen
David M. Kastenberg
Cuckoo Choudhary
Leo C. Katz
Anthony DiMarino
Juan P. Palazzo
Publication date
01-03-2008
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-007-9904-3

Other articles of this Issue 3/2008

Digestive Diseases and Sciences 3/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.